Cancer 20no 20longer 20defined 20by 20tissue 20of 20origin
Logo

Genomic Expression Inc

RNA platform for Next Generation Cures. By analyzing RNA we can detect disease, monitor health and design cures

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location Boston, MA, US
  • Currency USD
  • Founded July 2012
  • Employees 15
  • Incorporation Type C-corp
  • Website genomicexpression.com

Company Summary

Commercial Stage RNA Platform For Next Generation Cures in Cancer and Infectious Diseases

By analyzing RNA we can detect disease, monitor health and design next generation cures.

The OneRNA® Platform enables the design of mRNA vaccines as well as the repurposing of existing drugs on an individual patient basis.

OneRNA® is a disease agnostic exponentially scalable platform, CLIA validated in several clinical studies

Team

  • Inventor of the GEx's technologies
    PhD in Genetics at the JFK Institute
    Strong innovation track record

  • 20+ years of management experience
    Deal resume north of $1 billion
    Master’s in Chemical Engineering

  • Photo
    VP Data

    MIT, creator of products. CEO and Vice President of Engineering and Marketing for public and private companies. Coder at heart.

  • Default avatar
    Jesper Zeuthen
    CMO, PhD

    Co-founder of GenMab & Topotarget
    Raised more than $650 for Bankinvest
    Karolinska, The Danish Cancer Society

  • C093612f 86b1 4848 af7f c2d4afb3a96b
    Medical Director, MD, PhD

    Owner Medical Director at Molecular Diagnostic Laboratory, LLC, Professor Microbiology at Naugatuck Valley Community College

Advisors

  • Default avatar
    Duane Morris LLP
    Lawyer
    Unconfirmed
    Default avatar
    FullSky Partners
    Unconfirmed
    Default avatar
    FullSky Partners
    Unconfirmed
  • Default avatar
    Berdon, CPA
    Unconfirmed

Previous Investors

  • Default avatar
    Centurion Holding in New York http://www.centurionh.com
    Unconfirmed
    Default avatar
    Friends and Family, Founders
    Unconfirmed